Carcinoma of the Vulva

1

Review clinical trials related to Carcinoma of the Vulva. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva.

Participants needed: 10
Trial details
Age: 18-120Biological sex: FemaleType: InterventionalSponsor: Alpha Tau Medical LTD.Updated: Jan 31, 2024
Eligibility criteria

Histologically confirmed newly diagnosed or recurrent (local) vulva SCC with or... [+16]

Concomitant chemotherapy or immunotherapy within the past 4 weeks [+12]